JPWO2020123753A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020123753A5 JPWO2020123753A5 JP2021533523A JP2021533523A JPWO2020123753A5 JP WO2020123753 A5 JPWO2020123753 A5 JP WO2020123753A5 JP 2021533523 A JP2021533523 A JP 2021533523A JP 2021533523 A JP2021533523 A JP 2021533523A JP WO2020123753 A5 JPWO2020123753 A5 JP WO2020123753A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- acid sequence
- orf1
- synthetic
- orf2
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024075358A JP2024102242A (ja) | 2018-12-12 | 2024-05-07 | 細胞内治療モダリティを送達するためのアネロソーム |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862778866P | 2018-12-12 | 2018-12-12 | |
| US201862778851P | 2018-12-12 | 2018-12-12 | |
| US62/778,851 | 2018-12-12 | ||
| US62/778,866 | 2018-12-12 | ||
| PCT/US2019/065874 WO2020123753A2 (en) | 2018-12-12 | 2019-12-12 | Anellosomes for delivering intracellular therapeutic modalities |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024075358A Division JP2024102242A (ja) | 2018-12-12 | 2024-05-07 | 細胞内治療モダリティを送達するためのアネロソーム |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022514501A JP2022514501A (ja) | 2022-02-14 |
| JPWO2020123753A5 true JPWO2020123753A5 (https=) | 2022-12-20 |
| JP2022514501A5 JP2022514501A5 (https=) | 2022-12-20 |
Family
ID=69160334
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021533523A Withdrawn JP2022514501A (ja) | 2018-12-12 | 2019-12-12 | 細胞内治療モダリティを送達するためのアネロソーム |
| JP2024075358A Pending JP2024102242A (ja) | 2018-12-12 | 2024-05-07 | 細胞内治療モダリティを送達するためのアネロソーム |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024075358A Pending JP2024102242A (ja) | 2018-12-12 | 2024-05-07 | 細胞内治療モダリティを送達するためのアネロソーム |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220040117A1 (https=) |
| EP (1) | EP3894567A2 (https=) |
| JP (2) | JP2022514501A (https=) |
| KR (1) | KR20210131308A (https=) |
| CN (1) | CN114127302A (https=) |
| AU (1) | AU2019396516B2 (https=) |
| BR (1) | BR112021009282A2 (https=) |
| CA (1) | CA3119339A1 (https=) |
| IL (1) | IL283771A (https=) |
| MX (1) | MX2021006941A (https=) |
| WO (1) | WO2020123753A2 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021011124A2 (pt) * | 2018-12-12 | 2022-03-15 | Flagship Pioneering Innovations V Inc | Anelossomos e métodos de uso |
| JP2022513459A (ja) * | 2018-12-12 | 2022-02-08 | フラッグシップ パイオニアリング イノベーションズ ブイ， インコーポレイテッド | タンパク質代替治療モダリティを送達するためのアネロソーム |
| AU2021288320A1 (en) * | 2020-06-12 | 2023-01-19 | Flagship Pioneering Innovations V, Inc. | Tandem anellovirus constructs |
| US20250059559A1 (en) | 2021-12-15 | 2025-02-20 | Flagship Pioneering Innovations V, Inc. | Surface-modified viral particles and modular viral particles |
| US20240415978A1 (en) * | 2023-06-14 | 2024-12-19 | Flagship Pioneering Innovations V, Inc. | Anellovectors for delivery of effectors to the central nervous system |
| TW202529819A (zh) | 2023-10-13 | 2025-08-01 | 美商旗艦先鋒創新公司 | 組織特異性指環載體(anellovector)遞送 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6395472B1 (en) * | 1999-02-05 | 2002-05-28 | Abbott Laboratories | Methods of utilizing the TT virus |
| IL271275B1 (en) * | 2017-06-13 | 2026-04-01 | Flagship Pioneering Innovations V Inc | Preparations containing croons and their uses |
-
2019
- 2019-12-12 WO PCT/US2019/065874 patent/WO2020123753A2/en not_active Ceased
- 2019-12-12 EP EP19836313.7A patent/EP3894567A2/en active Pending
- 2019-12-12 BR BR112021009282-0A patent/BR112021009282A2/pt unknown
- 2019-12-12 MX MX2021006941A patent/MX2021006941A/es unknown
- 2019-12-12 CA CA3119339A patent/CA3119339A1/en active Pending
- 2019-12-12 US US17/413,123 patent/US20220040117A1/en active Pending
- 2019-12-12 JP JP2021533523A patent/JP2022514501A/ja not_active Withdrawn
- 2019-12-12 KR KR1020217021774A patent/KR20210131308A/ko active Pending
- 2019-12-12 CN CN201980091151.3A patent/CN114127302A/zh active Pending
- 2019-12-12 AU AU2019396516A patent/AU2019396516B2/en active Active
-
2021
- 2021-06-07 IL IL283771A patent/IL283771A/en unknown
-
2024
- 2024-05-07 JP JP2024075358A patent/JP2024102242A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN114736901B (zh) | 用于减少pd-l1表达的寡核苷酸 | |
| US5567604A (en) | Anti-viral guanosine-rich oligonucleotides | |
| US20030125241A1 (en) | Therapeutic uses of LNA-modified oligonucleotides in infectious diseases | |
| Prasad et al. | Resistance of cynomolgus monkeys to Nipah and Hendra virus disease is associated with cell-mediated and humoral immunity | |
| CN1871350A (zh) | 用于引发肿瘤细胞致死的核酸 | |
| KR101898177B1 (ko) | 톨－유사 수용체 기반 면역 반응을 조절하기 위한 면역 조절 올리고누클레오티드 （ｉｒｏ） 화합물 | |
| JPWO2020123773A5 (https=) | ||
| WO1999015643A2 (en) | ANTISENSE OLIGONUCLEOTIDE COMPOSITIONS TARGETED TO ANGIOTENSI N CONVERTING ENZYME mRNA AND METHODS OF USE | |
| WO1992001786A1 (en) | Portable ribozyme cassettes, dna sequences containing them, ribozymes encoded by these dna sequences, and compositions containing these ribozymes | |
| JP2023506546A (ja) | Ｂ型肝炎ウイルス感染症を処置するためのｓｅｐｔ９阻害剤の使用 | |
| JPWO2020123753A5 (https=) | ||
| JPWO2020123795A5 (https=) | ||
| WO2013012835A2 (en) | Sirna useful in the treatment of flavivirus infection | |
| CN115989321B (zh) | 病毒制剂、用于配制病毒制剂的溶液及其用途 | |
| JP2023506540A (ja) | Ｂ型肝炎ウイルス感染を処置するためのｓｃａｍｐ３阻害剤の使用 | |
| JPWO2020123816A5 (https=) | ||
| CN118043461A (zh) | 方法 | |
| CN1770978A (zh) | 利用ssDNA治疗HSV相关病理 | |
| US20170253879A1 (en) | APTAMER-RNAi THERAPEUTIC COMPOSITIONS | |
| JP2023506954A (ja) | Ｂ型肝炎ウイルス感染を処置するためのｓａｒａｆ阻害剤の使用 | |
| CN117838863A (zh) | 一种抑制d2hgdh的核酸分子、抑制剂及其用途 | |
| CN103597075A (zh) | 用于选择性地杀伤细胞的生物活性核苷酸分子、其用途及应用试剂盒 | |
| EP3680334B1 (en) | Double-stranded rna molecule targeting ckip-1 and use thereof | |
| CN115873851A (zh) | 一种抗棘球绦虫的药物靶点、靶向棘球绦虫甲基化酶的试剂、试剂盒及其应用 | |
| CN101173275B (zh) | 抑制sars冠状病毒m蛋白基因表达的小干扰rna及其编码基因与应用 |